Skip to main content
. 2019 Dec 31;20:1. doi: 10.1186/s12884-019-2665-0

Table 2.

Prevalence of UTI

Number Percent 95% CI (%)
First adequate screening specimena 4034
  > 100,000 CFU/mL, symptomatic 47 1.2 0.9–1.5
  > 100,000 CFU/mL, asymptomatic 183 4.5 3.9–5.2
 1000- < 100,000 CFU/mL, symptomatic 130 3.2 2.7–3.8
 1000- < 100,000 CFU/mL, asymptomatic 469 11.6 10.7–12.6
 No Growth (Normal) 3205 79.5 78.2–80.7
First Test of cure specimen 276
  > 100,000 CFU/mL, symptomatic 5 1.8 0.8–4.3
  > 100,000 CFU/mL, asymptomatic 36 13.0 9.6–17.7
 1000- < 100,000 CFU/mL, symptomatic 15 5.4 3.3–8.9
 1000- < 100,000 CFU/mL, asymptomatic 34 12.3 9.0–16.9
 No Growth (Normal) 186 67.4 62.1–73.2
Second Test of cure specimen 42
  > 100,000 CFU/mL, symptomatic 2 4.8 1.2–18.4
  > 100,000 CFU/mL, asymptomatic 8 19.0 10.2–35.5
 1000- < 100,000 CFU/mL, symptomatic 1 2.4 0.3–16.5
 1000- < 100,000 CFU/mL, asymptomatic 6 14.3 6.8–30.0
 No Growth (Normal) 25 59.5 46.4–76.4

aThis table presents by order of adequate specimen. That is, some specimens listed under “1st specimen”, include a small number of specimens that were in fact second specimen collected (but represented first testable/non-contaminated specimen)